Tocagen
San Diego, US · Founded 2007 · Delaware corporation · 1 known investors
Founders & leadership
Tocagen was founded in 2007 by Harry Gruber.
HG
Harry GruberFounder
TD
Thomas DarcyExecutive
DB
Dennis BermanExecutive
DJ
Douglas JollyNamed on SEC filing
Board
FH
Faheem HasnainBoard director
LK
Lori KunkelBoard director
DR
David R. ParkinsonBoard director
PS
Paul SchimmelBoard director
FM
Franklin M. BergerBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$83.3M disclosed across 4 rounds · 2012–2023
▶$25MraisedAug 2023 · 27 investors · BiotechnologyRule 506(b)
▶$25MraisedAug 2023 · 27 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony RileyExecutive Officer
- Stephen DobersteinDirector
- Scott BrunDirector
- Lawrence EichenfieldDirector
- Hubert ChenExecutive Officer
- Steven KornfeldDirector
- David GryskaDirector
- Barbara FinkDirector
- Donald WilliamsDirector
- Paul WagnerExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $25M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedMar 2017 · 107 investors · PharmaceuticalsRule 506(b)
▶$10.9MraisedMar 2017 · 107 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas DarcyExecutive Officer, Director
- Faheem HasnainDirector
- Harry GruberExecutive Officer, Director
- Mark FolettaExecutive Officer
- Douglas JollyExecutive Officer
- David R. ParkinsonDirector
- Franklin M. BergerDirector
- Lori KunkelDirector
- Dennis BermanExecutive Officer, Director
- Martin J DuvallExecutive Officer, Director
- Paul SchimmelDirector
- Offering amount
- $13M
- Amount sold
- $10.9M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$46.2MraisedOct 2015 · 250 investors · PharmaceuticalsRule 506(b)
▶$46.2MraisedOct 2015 · 250 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas DarcyExecutive Officer, Director
- Dennis BermanExecutive Officer, Director
- Faheem HasnainDirector
- Harry GruberExecutive Officer, Director
- Lori KunkelDirector
- Douglas JollyExecutive Officer
- David R. ParkinsonDirector
- Paul SchimmelDirector
- Franklin M. BergerDirector
- Offering amount
- $50.4M
- Amount sold
- $46.2M
- Minimum investment
- $10.5K
- Sales commissions
- $14K
- Placement agents
- Newbridge Securities Corporation
- First sale
- May 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedMar 2012 · 4 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedMar 2012 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dennis BermanExecutive Officer, Director
- Douglas JollyExecutive Officer
- Harry GruberExecutive Officer, Director
- Thomas DarcyExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1.1M
- Minimum investment
- $200K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $224.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $269K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Tocagen?
- Tocagen was founded by Harry Gruber in 2007.
- Who are Tocagen's investors?
- Tocagen's investors include BioBrit.
- How much funding has Tocagen raised?
- Tocagen has disclosed $83.3M raised across 4 rounds.
- Where is Tocagen headquartered?
- Tocagen is headquartered in San Diego, US.